Prostate cancer intervention
- 1 October 2003
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 114 (4) , 43-49
- https://doi.org/10.3810/pgm.2003.10.1506
Abstract
Cancer screening by PSA testing is widespread in the United States, and treatment recommendations encourage early therapy. Yet controversy about patient care persists because evidence demonstrating that these approaches improve the length and quality of a man's life is lacking. Physicians can assist their patients by first providing a balanced presentation of the known risks and benefits of prostate cancer detection and treatment and then incorporating patient preferences into medical decisions. Success in shared decision making may increase with use of patient education materials to convey most of the time-consuming and challenging information. At least two of the many materials developed can be easily administered with very few resources and independent of primary care encounters.Keywords
This publication has 15 references indexed in Scilit:
- Screening Men for Prostate and Colorectal Cancer in the United StatesJAMA, 2003
- Prostate cancer epidemiologyThe Lancet, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Screening for Prostate Cancer: Recommendation and RationaleAnnals of Internal Medicine, 2002
- Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and ConnecticutBMJ, 2002
- Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidenceBJU International, 2000
- Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?JAMA, 2000
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part III: Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer MortalityJNCI Journal of the National Cancer Institute, 1999
- Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reductionThe Prostate, 1999
- Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA changeCancer, 1994